Success Story: Overcoming an RFE to Achieve NIW Approval for a Bioinformatics Expert from India
Client’s Testimonial:
"I would like to thank the Chen attorneys who worked on my EB-2 NIW petition, they have been thorough in their approach since day 1 with timely feedback. I appreciate the strong customized response they drafted to each point raised in the RFE. They have been supportive throughout and answered all my questions with lots of patience. I recommend Chen immigration services particularly to computational/life science researchers; they know how to present the stronger aspects of a researcher’s profile to the USCIS.”
On April 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Bioinformatics Analyst in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Bioinformatics Analyst
Country of Origin: India
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: April 13th, 2026
Processing Time: 7 months, 9 days
Case Summary:
Our firm is pleased to share the approval of an EB-2 NIW (National Interest Waiver) petition for a bioinformatics analyst in the field of bioinformatics, specializing in multi-omic data analysis, transcriptomics, and host immune response mechanisms in the context of infectious disease and vaccine research. Despite a Request for Evidence (RFE) being issued, our expert team prepared a thorough and compelling response, and we are proud to celebrate this well-deserved approval in over 7 months.
Client Background and Proposed Endeavor
Holding a Ph.D. in Bioinformatics along with advanced training in bioinformatics and microbiology, this researcher brings deep expertise in multi-omic data analysis and infectious disease research. Currently employed as a bioinformatics analyst in a cutting-edge research environment, the proposed endeavor is to continue leveraging transcriptomic and multi-omic approaches to uncover host immune mechanisms in the context of vaccination and pathogenic exposure, to improve vaccine efficacy, guide drug repurposing strategies, and extend these insights to broader human health applications.
National Significance of the Research
We emphasized that this research carries significant importance and far-reaching implications for the United States. This work addresses critical national priorities in public health, including pandemic preparedness and infectious disease prevention, areas of growing urgency as emerging threats continue to challenge global health security. It also supports federal initiatives aimed at accelerating therapeutic development through drug repurposing, a strategy recognized as essential to reducing the high costs and lengthy timelines of traditional drug discovery. Furthermore, the proposed endeavor aligns with formally identified critical and emerging technology areas spanning multi-omics, bioinformatics, and computational biology, underscoring its strategic importance to U.S. technological leadership and national security.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted exceptional credentials:
- Publications: An impressive portfolio of 9 peer-reviewed journal articles (2 of them first-authored), 2 first-authored peer-reviewed conference articles, 1 first-authored preprint, and 1 first-authored book chapter.
- Citations: The published body of work has been cited 440 times.
Case Outcome
This researcher's impactful contributions to transcriptomic analysis, vaccine immunology, and infectious disease bioinformatics position them to make meaningful and lasting contributions to U.S. public health and pandemic preparedness for years to come. We are honored to have supported this journey and extend our sincere best wishes for continued success in both research and career pursuits.